InvestorsHub Logo
Replies to #38 on Mid Cap Ideas
icon url


12/29/23 10:06 PM

#39 RE: gfp927z #38

>>> Medpace Holdings, Inc. (MEDP)

Last on our list of biostocks to buy is Medpace Holdings, Inc. (NASDAQ:MEDP), a medical device services & drug research company that offers scientifically-driven clinical development services in the pharmaceutical, medical device, and biotechnology industries. It partners with several companies in the industry and provides them with product development services and execution of clinical trials. MEDP also offers full-service Phase I-IV clinical development services up to post-marketing clinical support. Its clinical trial services include bio-analytical laboratory services, imaging services, clinical human pharmacology, and electrocardiography reading support for clinical trials.

MEDP’s strong third quarter has showcased impressive results, with revenue growing 28.3% YoY. It also beat earnings estimates by 8.82% and is highly recommended by analysts. Even though the company experienced a slight dip in its net income margin to YoY (from 17.2% to 14.3%), its GAAP net income rose to $70.6 million and a strong EBITDA margin of 18.3%. Its consistent momentum and growth make it one of our top choices for biotech stocks right now.